Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khalid Saeed

Showing results (41-50 of 229) with videos related to

Pageof 23
Sort By:
Trials|August 24, 2020
Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trialJaved Akram, Shehnoor Azhar, Muhammad Shahzad, et al.
Frontiers in Public Health|April 5, 2021
Physician-Patient Language Discordance and Poor Health Outcomes: A Systematic Scoping ReviewNaomi Cano-Ibáñez, Yasmin Zolfaghari, Carmen Amezcua-Prieto, et al.
Microbiology Spectrum|December 16, 2025
Profiling of BDQ-induced transcriptome suggests amino acid metabolism and stress responses as alternate mechanisms contributing to BDQ tolerance in <i>Mycobacterium tuberculosis</i>Dania Khalid Saeed, Sadia Shakoor, Javaria Ashraf, et al.
Pharmacological Research|September 3, 2019
Necroptosis signaling in liver diseases: An updateWaqar Khalid Saeed, Dae Won Jun, Kiseok Jang, et al.
Annals of Translational Medicine|February 11, 2021
A narrative review of malnutrition in chronic liver diseaseSoan Shin, Dae Won Jun, Waqar Khalid Saeed, et al.
Trials|August 11, 2020
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trialJaved Akram, Shehnoor Azhar, Muhammad Shahzad, et al.
Trials|February 16, 2022
Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trialJaved Akram, Shehnoor Azhar, Muhammad Shahzad, et al.
Pakistan Journal of Medical Sciences|July 8, 2022
Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and HydroxychloquineShehnoor Azhar, Javed Akram, Muhammad Shahzad, et al.
Cureus|November 7, 2022
Aerococcus Urinae Endocarditis: A Case Report and Literature ReviewKhalid Saeed Al-Asad, Naveed Mazhar, Shaurya Srivastava, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|October 26, 2020
From adversity to resilience in the COVID-19 era: strengthening mental health systems in the Eastern Mediterranean RegionJulian Eaton, Atif Rahman, Richard Gater, et al.
Pageof 23

Showing results (41-50 of 229) with videos related to

Sort By:
Pageof 23
Trials|August 24, 2020
Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trialJaved Akram, Shehnoor Azhar, Muhammad Shahzad, et al.
Frontiers in Public Health|April 5, 2021
Physician-Patient Language Discordance and Poor Health Outcomes: A Systematic Scoping ReviewNaomi Cano-Ibáñez, Yasmin Zolfaghari, Carmen Amezcua-Prieto, et al.
Microbiology Spectrum|December 16, 2025
Profiling of BDQ-induced transcriptome suggests amino acid metabolism and stress responses as alternate mechanisms contributing to BDQ tolerance in <i>Mycobacterium tuberculosis</i>Dania Khalid Saeed, Sadia Shakoor, Javaria Ashraf, et al.
Pharmacological Research|September 3, 2019
Necroptosis signaling in liver diseases: An updateWaqar Khalid Saeed, Dae Won Jun, Kiseok Jang, et al.
Annals of Translational Medicine|February 11, 2021
A narrative review of malnutrition in chronic liver diseaseSoan Shin, Dae Won Jun, Waqar Khalid Saeed, et al.
Trials|August 11, 2020
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trialJaved Akram, Shehnoor Azhar, Muhammad Shahzad, et al.
Trials|February 16, 2022
Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trialJaved Akram, Shehnoor Azhar, Muhammad Shahzad, et al.
Pakistan Journal of Medical Sciences|July 8, 2022
Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and HydroxychloquineShehnoor Azhar, Javed Akram, Muhammad Shahzad, et al.
Cureus|November 7, 2022
Aerococcus Urinae Endocarditis: A Case Report and Literature ReviewKhalid Saeed Al-Asad, Naveed Mazhar, Shaurya Srivastava, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|October 26, 2020
From adversity to resilience in the COVID-19 era: strengthening mental health systems in the Eastern Mediterranean RegionJulian Eaton, Atif Rahman, Richard Gater, et al.
Pageof 23